GSK Plc (GSK)
GSK Market Cap: 96.24B for Jan. 21, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| AstraZeneca PLC | 276.56B |
| Biodexa Pharmaceuticals Plc | 1.787M |
| AnaptysBio, Inc. | 1.254B |
| NuCana Plc | 13.48M |
| Mereo BioPharma Group Plc | 80.04M |
Market Cap Related Metrics
| PE Ratio | 13.66 |
| PS Ratio | 2.348 |
| PEG Ratio | 0.1066 |
| Price to Book Value | 4.427 |
| Price to Free Cash Flow | 17.49 |
| Price | 47.89 |
| Earnings Yield | 7.32% |
| PEGY Ratio | 0.1037 |
| Operating PE Ratio | 9.992 |
| Normalized PE Ratio | 12.08 |